ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

4 links0 made here, not in the record8 judgments2 judges (our rules as one)1 record change seen
Model not recordedOur rulesRecord updated on ClinicalTrials.gov
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT07254585SYS6010 Combined WithEnlonstobart In RecurrentOr Metastatic Head And NeckSquamous Cell CarcinomaCSPC Megalith BiopharmaceuticaPhase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 19 · ClinicalTrials.gov record · Version of 2026-10-19Version of 2026-10-19CONDITIONSSquamous Cell Carcinoma of …The registry's MeSH filing›Nov 14 · Our condition-kind rule · Finest filed termAs of now · Our main-condition rule (R9) · Main conditionMain conditionDRUGSAnti-EGFR Antibody-drug Con…Entry “SYS6010 injection”, read by ou…›Nov 1 · A model not recorded · TestedNov 18 · Our role rule · TestedTestedEnlonstobartEntry “Enlonstobart injection”, read …›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · TestedBackgroundPembrolizumabEntry “Pembrolizumab injection”, read…›Nov 1 · A model not recorded · BackgroundNov 18 · Our role rule · BackgroundBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Anti-EGFR Antibody-drug Conjugate CPO301

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “SYS6010 injection”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Tested
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Oct 19The record itselfClinicalTrials.gov recordVersion of 2026-10-19Record change
Nov 1Anti-EGFR Antibody-drug Conjugate CPO301A model not recordedTestedCurrent
Nov 1EnlonstobartA model not recordedBackgroundCurrent
Nov 1PembrolizumabA model not recordedBackgroundCurrent
Nov 14Squamous Cell Carcinoma of Head and NeckOur condition-kind ruleFinest filed termCurrent
Nov 18Anti-EGFR Antibody-drug Conjugate CPO301Our role ruleTestedAgrees
Nov 18EnlonstobartOur role ruleTestedOverridden
Nov 18PembrolizumabOur role ruleBackgroundAgrees
As of nowSquamous Cell Carcinoma of Head and NeckOur main-condition rule (R9)Main conditionCurrent